Javelin Pharmaceuticals, Inc

(AMEX:JAV)
  Sep 30, 2008 Jun 30, 2008 Mar 31, 2008 Dec 31, 2007
Cash Flow Statement
Cash At Beginning Of Period 15,931 15,931 15,931 9,273
Cash At End Of Period 34,665 41,628 22,243 15,931
Net Change In Cash And Cash Equivalents 18,733 25,697 6,312 6,658
Effect Of Exchange Rate Changes — — — —
Net Income Or Loss -29,703 -18,833 -9,773 -31,031
Cash From Operating Activities
Depreciation Expenses 207 121 41 98
Amortization Expenses — -6 -6 -2
Amortization Of Intangibles Expenses 168 112 56 4
Deferred Income Taxes — — — —
Operating Gains Or Losses -35 -35 -35 —
Extraordinary Gains Or Losses — — — —
Increase Or Decrease In Receivables — — — 114
Increase Or Decrease In Inventories -1,923 -1,640 -551 -116
Increase Or Decrease In Prepaid Expenses 396 499 -86 -1,089
Increase Or Decrease In Other Current Assets 396 499 -86 -1,089
Increase Or Decrease In Payables — — — —
Increase Or Decrease In Other Current Liabilities 2,025 -399 -434 3,007
Increase Or Decrease In Other Working Capital 57 81 103 426
Other Non Cash Items — — — —
Net Cash From Continuing Operations 2,656 1,732 844 3,460
Net Cash From Discontinued Operations -26,153 -18,368 -9,841 -25,130
Net Cash From Operating Activities — — — —
Cash From Investing Activities
Sale Of Property Plant And Equipment — — — —
Sale Of Long Term Investments — — — —
Sale Of Short Term Investments — — — —
Purchase Of Property Plant And Equipment -935 -587 -446 -406
Acquisitions — — — -1,800
Purchase Of Long Term Investments — — — —
Purchase Of Short Term Investments -2,100 -2,100 -2,100 -57,401
Other Investing Changes Net — — — —
Cash From Discontinued Investing Activities — — — —
Net Cash From Investing Activities 18,617 17,790 15,930 -12,047
Cash From Financing Activities
Issuance Of Debt 28,037 28,037 222 47,333
Issuance Of Capital Stock — — — —
Repayment Of Debt -1,768 — — —
Repurchase Of Capital Stock — — — —
Payment Of Cash Dividends — -1,762 — -3,498
Net Other Financing Charges — -1,762 — -3,498
Cash From Discontinued Financing Activities — — — —
Net Cash From Financing Activities 26,269 26,275 222 43,835